Logo

Rheumatoid arthritis drug shows promise for treating excessive inflammation due to COVID-19

Rheumatoid arthritis drug shows promise for treating excessive inflammation due to COVID-19

The COVID-19 pandemic caused by SARS-CoV-2 infection is marked by excessive inflammation of several organs, leading to multi-organ failure. The recognition of the virus by our bodies triggers severe immune responses, causing a "cytokine storm," which can lead to acute lung injury and acute respiratory distress syndrome.

👉 Full Story